RIPK1 inhibition and RIPK3 deficiency have been reported to delay the onset of motor impairment and prevent axonal myelination abnormalities in mice with ALS expressing a mutant form of superoxide dismutase 1 (SOD1) (SOD1G93A mice) [110]. The gene discussed is RIPK3; the disease is amyotrophic lateral sclerosis.